Sodium–glucose cotransporter 2 inhibition suppresses HIF-1α-mediated metabolic switch from lipid oxidation to glycolysis in kidney tubule cells of diabetic mice
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sodium–glucose cotransporter 2 inhibition suppresses HIF-1α-mediated metabolic switch from lipid oxidation to glycolysis in kidney tubule cells of diabetic mice
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 11, Issue 5, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-22
DOI
10.1038/s41419-020-2544-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prolyl Hydroxylase Domain Inhibitor Protects against Metabolic Disorders and Associated Kidney Disease in Obese Type 2 Diabetic Mice
- (2020) Mai Sugahara et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Prolyl hydroxylase inhibition protects the kidneys from ischemia via upregulation of glycogen storage
- (2019) Marie Ito et al. KIDNEY INTERNATIONAL
- Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy
- (2019) Ryoichi Bessho et al. Scientific Reports
- The oral hypoxia-inducible factor prolyl hydroxylase inhibitor enarodustat counteracts alterations in renal energy metabolism in the early stages of diabetic kidney disease
- (2019) Sho Hasegawa et al. KIDNEY INTERNATIONAL
- Update on Diabetic Nephropathy: Core Curriculum 2018
- (2018) Kausik Umanath et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- SGLT2 Inhibition for the Prevention and Treatment of Diabetic Kidney Disease: A Review
- (2018) Radica Z. Alicic et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Sodium–glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice
- (2018) Shinji Tanaka et al. KIDNEY INTERNATIONAL
- Mitochondrial dysfunction in diabetic kidney disease
- (2018) Josephine M. Forbes et al. Nature Reviews Nephrology
- The role of hypoxia-inducible factors in metabolic diseases
- (2018) Frank J. Gonzalez et al. Nature Reviews Endocrinology
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease
- (2017) Christoph Wanner et al. CIRCULATION
- HIF-1 Mediates Renal Fibrosis in OVE26 Type 1 Diabetic Mice
- (2016) Bijaya K. Nayak et al. DIABETES
- HIF1α and metabolic reprogramming in inflammation
- (2016) Sarah E. Corcoran et al. JOURNAL OF CLINICAL INVESTIGATION
- Nephron Protection in Diabetic Kidney Disease
- (2016) Hans-Joachim Anders et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond
- (2015) Patrick H. Maxwell et al. Nature Reviews Nephrology
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diabetic Kidney Disease: A Report From an ADA Consensus Conference
- (2014) Katherine R. Tuttle et al. DIABETES CARE
- Molecular mechanisms of diabetic kidney disease
- (2014) Kimberly Reidy et al. JOURNAL OF CLINICAL INVESTIGATION
- Activation of Hypoxia-Inducible Factors Prevents Diabetic Nephropathy
- (2014) L. Nordquist et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development
- (2014) Hyun Mi Kang et al. NATURE MEDICINE
- HIF-1-Mediated Suppression of Acyl-CoA Dehydrogenases and Fatty Acid Oxidation Is Critical for Cancer Progression
- (2014) De Huang et al. Cell Reports
- High altitude may alter oxygen availability and renal metabolism in diabetics as measured by hyperpolarized [1- 13 C]pyruvate magnetic resonance imaging
- (2013) Christoffer Laustsen et al. KIDNEY INTERNATIONAL
- Mechanisms of Diabetic Complications
- (2013) Josephine M. Forbes et al. PHYSIOLOGICAL REVIEWS
- Mortality Rates in Trials of Subjects With Type 2 Diabetes
- (2013) E. Barkoudah et al. Journal of the American Heart Association
- The proximal tubule in the pathophysiology of the diabetic kidney
- (2011) Volker Vallon AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat
- (2011) Scott C. Thomson et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Glucose handling by the kidney
- (2011) Amanda Mather et al. KIDNEY INTERNATIONAL
- SGLT2 inhibitors: molecular design and potential differences in effect
- (2011) Masayuki Isaji KIDNEY INTERNATIONAL
- Specific metabolic rates of major organs and tissues across adulthood: evaluation by mechanistic model of resting energy expenditure
- (2010) ZiMian Wang et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Pathologic Classification of Diabetic Nephropathy
- (2010) T. W. C. Tervaert et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Glucose Control by the Kidney: An Emerging Target in Diabetes
- (2009) Olivera Marsenic AMERICAN JOURNAL OF KIDNEY DISEASES
- Activation of a HIF1α-PPARγ Axis Underlies the Integration of Glycolytic and Lipid Anabolic Pathways in Pathologic Cardiac Hypertrophy
- (2009) Jaya Krishnan et al. Cell Metabolism
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
- (2009) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology
- (2008) David J. Pagliarini et al. CELL
- The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
- (2008) Ralph J. DeBerardinis et al. Cell Metabolism
- Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats
- (2008) S. Han et al. DIABETES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation